Modeling and Control of Drug Delivery Systems 2021
DOI: 10.1016/b978-0-12-821185-4.00012-9
|View full text |Cite
|
Sign up to set email alerts
|

Smart Drug Delivery Systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…The growing interest in biomedical applications represents an intriguing and promising path for the advancement and utilization of multifunctional MOFs [2]. Among these applications, drug delivery [3,4] stands out as a critical aspect of the industry's success. For biological applications, particularly in drug delivery systems, non-toxic MOFs are thought to perform better than toxic MOFs.…”
Section: Introductionmentioning
confidence: 99%
“…The growing interest in biomedical applications represents an intriguing and promising path for the advancement and utilization of multifunctional MOFs [2]. Among these applications, drug delivery [3,4] stands out as a critical aspect of the industry's success. For biological applications, particularly in drug delivery systems, non-toxic MOFs are thought to perform better than toxic MOFs.…”
Section: Introductionmentioning
confidence: 99%
“…The drug payload of stimuli-responsive SDDS will be released when a biological or physical stimulus occurs, which needs to be specific to the application. For example, temperature-responsive, pH-responsive or redox-responsive nanocarriers (NCs) are the most widely described smart systems for biomedical uses [ 1 ]. The preparation of such SDDS is typically based on using stimuli-responsive polymers.…”
Section: Introductionmentioning
confidence: 99%